Sobi, Inc.
Clinical trials sponsored by Sobi, Inc., explained in plain language.
-
New drug tested to boost platelets in chronic blood disorder
Disease control CompletedThis study tested whether a drug called avatrombopag is safe and effective at raising platelet counts in Japanese adults with chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. Participants took the drug for 26 weeks, and researchers mea…
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated Apr 02, 2026 04:12 UTC
-
New hope for kids with rare bleeding disorder
Disease control CompletedThis study tested whether a medicine called avatrombopag could safely and effectively raise platelet counts in children with long-term immune thrombocytopenia (ITP), a condition that causes low platelets and increased bleeding risk. 75 children participated, receiving either the …
Phase: PHASE3 • Sponsor: Sobi, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC